title: Cross-fostering to prevent maternal cell transfer did not prevent vaccine-associated enhanced respiratory disease that occurred following heterologous influenza challenge of pigs vaccinated in the presence of maternal immunity.
abstract: Whole inactivated virus (WIV) vaccines for influenza A virus (IAV) provide limited cross-protection to diverse antigenic strains that are circulating or may emerge in a population. Maternal vaccination is used to protect neonatal animals from disease through passive transfer of immunity. It is desirable to vaccinate at a young age to induce active immunity that provides protection against infection before maternal immunity wanes. However, maternal-derived immunity (MDI; antibody or cells) can interfere with vaccine priming. Previous work indicates that vaccine-associated enhanced respiratory disease (VAERD) occurs in pigs following heterologous IAV challenge if pigs were previously vaccinated with WIV vaccine in the presence of matched MDI. However, the component of MDI (antibody or cells) that is required for the mispriming of piglet immunity has not been determined. While antibody from colostrum is absorbed into piglet circulation regardless of the sow from which it receives colostrum, transfer of maternal cells requires colostrum from the biological dam. We used cross-fostering (CF) as a tool to determine if maternal cells are required for the mispriming of piglet immunity upon WIV vaccination in the presence of MDI. Piglets vaccinated in the presence of MDI, regardless of CF, displayed characteristics of VAERD following heterologous challenge. MDI alone (no piglet vaccination) did not provide cross-protection against the antigenic variant. However, it did not induce VAERD. WIV vaccination provided complete protection against homologous challenge when delivered to piglets without MDI. Vaccination in the presence of MDI inhibited an increase in hemagglutination inhibiting (HI) antibody titers to vaccine antigen, but did not alter development of total immunoglobulin levels to vaccine virus. Taken together, the cellular component of MDI did not contribute to the mispriming of piglet immunity to WIV vaccine, but maternal-derived antibody (MDA) alone was sufficient. Future work is aimed at understanding how MDA alters WIV vaccine immunogenicity.
authors: 1 Virus and Prion Diseases Research Unit, National Animal Disease Center , USDA-ARS, Ames, Iowa.
authors: Crystal L
authors: CL
authors: Loving
authors: Susan L
authors: SL
authors: Brockmeier
authors: Amy L
authors: AL
authors: Vincent
authors: Phillip C
authors: PC
authors: Gauger
authors: Eraldo L
authors: EL
authors: Zanella
authors: Kelly M
authors: KM
authors: Lager
authors: Marcus E
authors: ME
authors: Kehrli
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D007112:Immunity, Maternally-Acquired / Q000502:physiology*; D007074:Immunoglobulin G / Q000097:blood; D053122:Influenza A Virus, H3N2 Subtype; D009976:Orthomyxoviridae Infections / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D012140:Respiratory Tract Diseases / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D013552:Swine; D013553:Swine Diseases / Q000276:immunology* / Q000821:virology; D014611:Vaccination; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D014765:Viral Vaccines